PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14703068-0	2003	Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer.	Epirubicin	38-48	erb-b2 receptor tyrosine kinase 2	Homo sapiens	84-88	
14703068-0	2003	Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer.	Epirubicin	38-48	erb-b2 receptor tyrosine kinase 2	Homo sapiens	89-92	
14703068-2	2003	Since neoadjuvant chemotherapy with epirubicin and docetaxel is increasingly used in advanced breast cancer, our purpose was to assess the influence of this neoadjuvant chemotherapy on the expression of the growth factor receptor HER2/neu.	Epirubicin	36-46	erb-b2 receptor tyrosine kinase 2	Homo sapiens	230-238